Masato Kono

3.1k total citations
90 papers, 2.1k citations indexed

About

Masato Kono is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Masato Kono has authored 90 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Pulmonary and Respiratory Medicine, 36 papers in Physiology and 20 papers in Epidemiology. Recurrent topics in Masato Kono's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (63 papers), Sarcoidosis and Beryllium Toxicity Research (28 papers) and Eosinophilic Disorders and Syndromes (15 papers). Masato Kono is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (63 papers), Sarcoidosis and Beryllium Toxicity Research (28 papers) and Eosinophilic Disorders and Syndromes (15 papers). Masato Kono collaborates with scholars based in Japan, United States and Australia. Masato Kono's co-authors include Takafumi Suda, Yutaro Nakamura, Naoki Inui, Noriyuki Enomoto, Tomoyuki Fujisawa, Hironao Hozumi, Dai Hashimoto, Kazuki Furuhashi, Yuzo Suzuki and Masato Karayama and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Masato Kono

89 papers receiving 2.1k citations

Peers

Masato Kono
Hironao Hozumi Japan
Yoshio Taguchi Japan
Takashi Ogura Japan
Ayodeji Adegunsoye United States
Mayra Mejía Mexico
Jan C. Grutters Netherlands
Αrgyris Τzouvelekis Greece
Miriana d’Alessandro Italy
Brett Ley United States
Masahide Yasui Japan
Hironao Hozumi Japan
Masato Kono
Citations per year, relative to Masato Kono Masato Kono (= 1×) peers Hironao Hozumi

Countries citing papers authored by Masato Kono

Since Specialization
Citations

This map shows the geographic impact of Masato Kono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masato Kono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masato Kono more than expected).

Fields of papers citing papers by Masato Kono

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masato Kono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masato Kono. The network helps show where Masato Kono may publish in the future.

Co-authorship network of co-authors of Masato Kono

This figure shows the co-authorship network connecting the top 25 collaborators of Masato Kono. A scholar is included among the top collaborators of Masato Kono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masato Kono. Masato Kono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suzuki, Yuzo, Masato Kono, Hirotsugu Hasegawa, et al.. (2023). Neutrophil–lymphocyte ratio in patients with idiopathic pleuroparenchymal fibroelastosis. BMJ Open Respiratory Research. 10(1). e001763–e001763. 6 indexed citations
2.
Suzuki, Yuzo, Masato Kono, Hirotsugu Hasegawa, et al.. (2023). Geriatric Nutritional Risk Index is a predictor of tolerability of antifibrotic therapy and mortality risk in patients with idiopathic pulmonary fibrosis. Respirology. 28(8). 775–783. 23 indexed citations
3.
Karayama, Masato, Takahito Suzuki, Kazutaka Mori, et al.. (2023). A predictive model for acute exacerbation of idiopathic interstitial pneumonias. European Respiratory Journal. 61(5). 2201634–2201634. 5 indexed citations
4.
Suzuki, Yuzo, Kazutaka Mori, Yuya Aono, et al.. (2022). Impact of antifibrotic therapy on lung cancer development in idiopathic pulmonary fibrosis. Thorax. 77(7). 727–730. 20 indexed citations
5.
Suzuki, Yuzo, Kazutaka Mori, Yuya Aono, et al.. (2021). Combined assessment of the GAP index and body mass index at antifibrotic therapy initiation for prognosis of idiopathic pulmonary fibrosis. Scientific Reports. 11(1). 18579–18579. 11 indexed citations
6.
Suzuki, Yuzo, Tomoyuki Fujisawa, Hiromitsu Sumikawa, et al.. (2020). Disease course and prognosis of pleuroparenchymal fibroelastosis compared with idiopathic pulmonary fibrosis. Respiratory Medicine. 171. 106078–106078. 21 indexed citations
7.
8.
Hozumi, Hironao, Hideki Yasui, Yuzo Suzuki, et al.. (2019). Frequency and clinical relevance of anti-cyclic citrullinated peptide antibody in idiopathic interstitial pneumonias. Respiratory Medicine. 154. 102–108. 9 indexed citations
9.
Kono, Masato, Yutaro Nakamura, Noriyuki Enomoto, et al.. (2019). Prognostic impact of an early marginal decline in forced vital capacity in idiopathic pulmonary fibrosis patients treated with pirfenidone. Respiratory Investigation. 57(6). 552–560. 8 indexed citations
10.
Inui, Naoki, Hironao Hozumi, Yusuke Inoue, et al.. (2018). Neutrophil gelatinase-associated lipocalin in patients with sarcoidosis. Respiratory Medicine. 138. S20–S23. 5 indexed citations
11.
Oyama, Yoshiyuki, Noriyuki Enomoto, Yuzo Suzuki, et al.. (2016). Evaluation of urinary desmosines as a noninvasive diagnostic biomarker in patients with idiopathic pleuroparenchymal fibroelastosis (PPFE). Respiratory Medicine. 123. 63–70. 14 indexed citations
12.
Enomoto, Yasunori, Naoki Inui, Katsuhiro Yoshimura, et al.. (2016). Lung cancer development in patients with connective tissue disease–related interstitial lung disease. Medicine. 95(50). e5716–e5716. 17 indexed citations
13.
Toyoshima, Mikio, et al.. (2015). Methotrexate-induced Accelerated Pulmonary Nodulosis. American Journal of Respiratory and Critical Care Medicine. 192(2). 252–253. 12 indexed citations
14.
Hozumi, Hironao, Noriyuki Enomoto, Masato Kono, et al.. (2015). Prognostic Significance of Anti-Aminoacyl-tRNA Synthetase Antibodies in Polymyositis/Dermatomyositis-Associated Interstitial Lung Disease: A Retrospective Case Control Study. PLoS ONE. 10(3). e0120313–e0120313. 67 indexed citations
15.
Inui, Naoki, Hideki Yasui, Masato Kono, et al.. (2014). Indacaterol and tiotropium combination therapy in patients with chronic obstructive pulmonary disease. Pulmonary Pharmacology & Therapeutics. 30. 11–15. 5 indexed citations
16.
Fujisawa, Tomoyuki, Hironao Hozumi, Masato Kono, et al.. (2014). Prognostic Factors for Myositis-Associated Interstitial Lung Disease. PLoS ONE. 9(6). e98824–e98824. 134 indexed citations
17.
Hozumi, Hironao, Yutaro Nakamura, Takeshi Johkoh, et al.. (2013). Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study. BMJ Open. 3(9). e003132–e003132. 115 indexed citations
18.
Nakamura, Yutaro, Takafumi Suda, Yusuke Kaida, et al.. (2012). Rheumatoid lung disease: Prognostic analysis of 54 biopsy-proven cases. Respiratory Medicine. 106(8). 1164–1169. 60 indexed citations
19.
Suda, Takafumi, Masato Kono, Yutaro Nakamura, et al.. (2010). Distinct prognosis of idiopathic nonspecific interstitial pneumonia (NSIP) fulfilling criteria for undifferentiated connective tissue disease (UCTD). Respiratory Medicine. 104(10). 1527–1534. 40 indexed citations
20.
Kono, Masato, et al.. (1961). Studies on hookworm immunity. III. The in vitro action (precipitate formation) of immune serum of hookworm.. Kiseichūgaku zasshi. 10(6). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hironao Hozumi Breakdown of academic impact, for papers by Yoshio Taguchi Breakdown of academic impact, for papers by Takashi Ogura Breakdown of academic impact, for papers by Ayodeji Adegunsoye Breakdown of academic impact, for papers by Mayra Mejía Breakdown of academic impact, for papers by Jan C. Grutters Breakdown of academic impact, for papers by Αrgyris Τzouvelekis Breakdown of academic impact, for papers by Miriana d’Alessandro Breakdown of academic impact, for papers by Brett Ley Breakdown of academic impact, for papers by Masahide Yasui
Rankless by CCL
2026